Stevenson I, Schiff A
Br J Clin Pharmacol. 2012; 1(4):337-8.
PMID: 22454890
PMC: 1402422.
DOI: 10.1111/j.1365-2125.1974.tb00264.x.
Lader M
Br J Clin Pharmacol. 2012; 1(4):281-3.
PMID: 22454878
PMC: 1402437.
DOI: 10.1111/j.1365-2125.1974.tb00252.x.
Palaniappun V, Ramachandran V, Somasundaram O
Indian J Psychiatry. 2011; 33(3):193-9.
PMID: 21927500
PMC: 2988307.
Ulrich S, Lauter J
Clin Pharmacokinet. 2002; 41(11):853-76.
PMID: 12190332
DOI: 10.2165/00003088-200241110-00004.
Furlanut M, Benetello P, Spina E
Clin Pharmacokinet. 1993; 24(4):301-18.
PMID: 8491058
DOI: 10.2165/00003088-199324040-00004.
Relationship between blood and cerebrospinal levels of the antidepressant agent viloxazine.
Elwan O, Adam H
Eur J Clin Pharmacol. 1980; 17(3):179-82.
PMID: 7363931
DOI: 10.1007/BF00561897.
Measurement of serum drug levels in the assessment of antidepressants.
Montgomery S
Br J Clin Pharmacol. 1980; 10(5):411-6.
PMID: 7002182
PMC: 1430140.
DOI: 10.1111/j.1365-2125.1980.tb01781.x.
Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
Lehmann L, Bowden C, Redmond F, Stanton B
Psychopharmacology (Berl). 1982; 77(2):193-7.
PMID: 6812139
DOI: 10.1007/BF00431947.
Benzodiazepines and tricyclic antidepressant plasma levels.
Silverman G, Braithwaite R
Br Med J. 1973; 3(5870):18-20.
PMID: 4717418
PMC: 1587933.
DOI: 10.1136/bmj.3.5870.18.
Letter: Variability in response to drugs.
Burrows G, Davies B
Br Med J. 1974; 4(5943):533.
PMID: 4434132
PMC: 1612626.
DOI: 10.1136/bmj.4.5943.533-b.
The effects of hypnotics on imipramine treatment.
Ballinger B, Presly A, Reid A, Stevenson I
Psychopharmacologia. 1974; 39(3):267-74.
PMID: 4427993
DOI: 10.1007/BF00421034.
The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis.
Perry P, Pfohl B, Holstad S
Clin Pharmacokinet. 1987; 13(6):381-92.
PMID: 3325215
DOI: 10.2165/00003088-198713060-00003.
Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
CORONA G, Cucchi M, Frattini P, Santagostino G, Schinelli S, Zerbi F
Psychopharmacology (Berl). 1990; 100(3):334-8.
PMID: 2315430
DOI: 10.1007/BF02244602.
[Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].
Buschsenschultz E, Pichot P, Boissier J
Psychopharmacologia. 1975; 41(2):187-95.
PMID: 1153607
DOI: 10.1007/BF00421078.
Letter: Effective dosage of tricyclic antidepressants.
Coppen A, Montgomery S, Lyle W
Br Med J. 1975; 1(5949):91-2.
PMID: 1109670
PMC: 1672275.
DOI: 10.1136/bmj.1.5949.91-b.
Prediction of response to chlorpromazine treatment in schizophrenics.
Sakurai Y, Nakahara T, Takahashi R
Psychopharmacologia. 1975; 44(2):195-203.
PMID: 1105634
DOI: 10.1007/BF00421010.
The relationship between nortriptyline plasms levels and clinical effects.
Kragh-Sorensen P
Proc R Soc Med. 1975; 68(2):99-102.
PMID: 1101270
PMC: 1863628.
Pharmacokinetic aspects of protriptyline plasma levels.
MOODY J, Whyte S, Macdonald A, Naylor G
Eur J Clin Pharmacol. 1977; 11(1):51-6.
PMID: 832658
DOI: 10.1007/BF00561788.
Depression during renal dialysis and following transplantation.
Rosser R
Proc R Soc Med. 1976; 69(11):832-4.
PMID: 794883
PMC: 1864734.
Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.
Kragh-Sorensen P, Hansen C, BAASTRUP P, Hvidberg E
Psychopharmacologia. 1976; 45(3):305-12.
PMID: 766041
DOI: 10.1007/BF00421145.
